Establishment Labs Holdings Inc (ESTA) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Establishment Labs Holdings Inc   (NASDAQ: ESTA)

Select the Financial Report: Select the Period:


Description of Establishment Labs Holdings Inc's Business Segments


Establishment Labs Holdings Inc is a leading global medical technology company that focuses on the development and commercialization of innovative medical devices, particularly in the realms of aesthetic and reconstructive surgery. Headquartered in Costa Rica, the company has established a strong international presence with operations and offices in key markets, including the United States, Australia, and Brazil. The companys product offerings and services can be comprehensively categorized into several segments:

1. Breast Implants

Establishment Labs is renowned for its advanced breast implant technologies, designed for both aesthetic enhancement and reconstruction following mastectomy or trauma. The primary highlight of their breast implant product line is the Motiva Implant Matrix, which exemplifies cutting-edge implant design and technology. This product is distinguished by several key features:

- Diverse Range of Options: The Motiva Implant Matrix comes in various sizes, shapes (round and anatomical), and textures (smooth and textured), catering to specific patient desires and anatomical requirements.

- Q Inside Safety Technology: A proprietary feature designed for enhanced safety and monitoring, this technology allows surgeons and patients to access data regarding implant performance via a secure and dedicated mechanism. This smart technology provides added peace of mind through the ability to track potential complications.

- Feel and Aesthetic Qualities: The implant is crafted to mimic the natural feel of breast tissue, incorporating materials that enhance softness while retaining durability and resilience.

Aesthetic Surgery

In supporting aesthetic surgical procedures, Establishment Labs provides an extensive array of surgical instruments and tools that are integral in executing various cosmetic surgeries. Products in this segment include:

- Surgical Instruments: High-quality instruments designed specifically for procedures like breast augmentation, facelifts, and body contouring.

- Minimally Invasive Devices: Innovations designed to facilitate procedures with reduced patient recovery times and improved outcomes, emphasizing patient safety and comfort.

- Protocols and Kits: Tailored surgical kits that include all the necessary tools for a specific procedure, ensuring that surgeons have immediate access to everything required throughout the surgical process.

Reconstruction Surgery

Establishment Labs plays a crucial role in the reconstructive surgery segment, particularly in breast reconstruction surgeries. Their offerings include:

- Tissue Expanders: Devices used in the initial stages of breast reconstruction to create space for permanent implants. These expanders allow for gradual stretching of the skin and tissue.

- Comprehensive Breast Reconstruction Solutions: The company provides integrated solutions that encompass a range of products, including both implants and supporting surgical instruments to facilitate breast reconstruction.

- Educational Resources: Materials and training sessions focused on the latest techniques in reconstructive surgery to ensure that surgeons are well-equipped to offer the best care to their patients.

Services

Beyond hardware products, Establishment Labs recognizes the importance of supporting medical professionals through various value-added services:

- Training and Education Programs: These initiatives are designed to keep surgeons informed about the latest advancements in techniques and technologies. They provide hands-on training, webinars, and workshops led by experienced professionals.

- Marketing Support: Tailored marketing resources to assist physicians in effectively showcasing their practices and attracting new patients. This service includes providing promotional materials, guidance on best practices in patient engagement, and shared market insights.

- Clinical Support: Dedicated clinical representatives that assist surgeons during procedures to ensure smooth operations and address any challenges that may arise in the operating room or during postoperative care.

Summary

In conclusion, Establishment Labs Holdings Inc epitomizes innovation in the fields of aesthetic and reconstructive surgery. With a comprehensive portfolio that includes advanced breast implant technologies like the Motiva Implant Matrix, a wide range of aesthetic and reconstructive surgical tools, and a robust suite of services tailored for practitioners, the company is committed to enhancing surgical outcomes and improving patient experiences. Their proactive approach to education and support empowers healthcare providers, enabling them to deliver exceptional care and achieve optimal results for their patients.


Composition of Establishment Labs Holdings Inc Revenues by Segments

 
Non-US    123.08 % of total Revenue
United States    65.57 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Non-US 83.13 123.08 %
United States 44.29 65.57 %
Total 67.54 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Non-US - -
United States - -
Total 31.73 % 13.83 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -11.75 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Establishment Labs Holdings Inc Divisions, Sales by Country

 
EMEA Europe Middle East Africa   EMEA Europe Middle East Africa Segment contribution to total sales 43.29 % of total Revenue
Latin America   Latin America Segment contribution to total sales 18.98 % of total Revenue
Asia-Pacific   Asia-Pacific Segment contribution to total sales 16.42 % of total Revenue
North America   North America Segment contribution to total sales 21.66 % of total Revenue


Twelve months ended 2025
ESTA s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 210.31 100 %
EMEA Europe Middle East Africa 91.05 43.29 %
Latin America 39.93 18.98 %
Asia-Pacific 34.54 16.42 %
North America 45.56 21.66 %


Twelve months ended 2025
ESTA s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -51.06 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total 27.06 % -
EMEA Europe Middle East Africa 16.42 % -
Latin America 14.08 % -
Asia-Pacific -28.65 % -
North America 933.04 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.